| |
The
AMIS Plus
national registry collects and analyzes data on patients with acute
myocardial infarction in Switzerland in the pre-admission,
hospital and follow-up phases. Emphasis is placed on the evaluation
of risk factors, diagnostics, urgent therapy strategies and treatment. AMIS
Plus data are important for quality assurance, assessing guidelines,
improving compliance with guidelines in clinical practice,
verifying whether results of randomized clinical trials are
translatable into everyday clinical practice,
investigating patient groups not extensively studied in large randomized
trials and improving therapeutic strategies.
|
